New CF drug combo passes first safety check in healthy volunteers
Knowledge-focused
Recruiting now
This early-stage study tests whether new drug combinations (SION-451 with SION-2222 or SION-109) are safe in healthy adults aged 18-55. It does not involve people with cystic fibrosis yet. The goal is to measure side effects and how the drugs move through the body, laying groundw…
Phase: PHASE1 • Sponsor: Sionna Therapeutics Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC